title: New series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors.
authors.affiliation: Gilead Sciences Inc., Foster City, California 94404, USA.
authors.forename: C U
authors.initials: CU
authors.lastname: Kim
authors.forename: L R
authors.initials: LR
authors.lastname: McGee
authors.forename: S H
authors.initials: SH
authors.lastname: Krawczyk
authors.forename: E
authors.initials: E
authors.lastname: Harwood
authors.forename: Y
authors.initials: Y
authors.lastname: Harada
authors.forename: S
authors.initials: S
authors.lastname: Swaminathan
authors.forename: N
authors.initials: N
authors.lastname: Bischofberger
authors.forename: M S
authors.initials: MS
authors.lastname: Chen
authors.forename: J M
authors.initials: JM
authors.lastname: Cherrington
authors.forename: S F
authors.initials: SF
authors.lastname: Xiong
authors.forename: L
authors.initials: L
authors.lastname: Griffin
authors.forename: K C
authors.initials: KC
authors.lastname: Cundy
authors.forename: A
authors.initials: A
authors.lastname: Lee
authors.forename: B
authors.initials: B
authors.lastname: Yu
authors.forename: S
authors.initials: S
authors.lastname: Gulnik
authors.forename: J W
authors.initials: JW
authors.lastname: Erickson
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D004285:Dogs; D017320:HIV Protease Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects*; D008297:Male; D013329:Structure-Activity Relationship; D013450:Sulfones / Q000494:pharmacology*
chemical_list: D017320:HIV Protease Inhibitors; D013450:Sulfones